• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Edward W. Cowen Addresses Current Management of Pustular Psoriasis

Video

Edward W. Cowen, MD, MHSc, senior clinician and acting branch chief, Dermatology Branch, National Institutes of Health, discusses treatment considerations for patients with different types of pustular psoriasis.

With no currently established standard of care for pustular psoriasis, treatment considerations depend on the extent and type of disease present in patients, said Edward W. Cowen, MD, MHSc, senior clinician and acting branch chief, Dermatology Branch, National Institutes of Health.


Transcript

Can you speak on the current standard of care for pustular psoriasis, including screening and treatment?

There really is not a specific standard of care based on current National Psoriasis Foundation guidelines for pustular psoriasis. Treatment does need to be tailored to the patient and will be determined by the extent of their disease, and whether or not they have systemic symptoms.

Many patients may have localized disease, which might be controllable with just aggressive topical therapy. However, other patients with difficult-to-control disease or with generalized disease will often require systemic treatment. So, this could include immunosuppressive therapies like cyclosporine or methotrexate, systemic retinoids like acitretin, or often some of the newer biologic therapies.

Related Videos
Coral Omene, MD, PhD, sitting for a vieo interview
Dr Ola Landgren
David Awad, PharmD, BCOP
Gordon Crofoot, MD, PA
Jaime Almandoz, MD, MBA
Screenshot of Coral Omene, MD, PhD
Dr Brian Slomovitz
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy (AMCP)
ASCO 2025
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.